Results 31 to 40 of about 878,311 (236)

Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. [PDF]

open access: yes, 2012
BACKGROUND: Transcatheter aortic-valve replacement (TAVR) is the recommended therapy for patients with severe aortic stenosis who are not suitable candidates for surgery. The outcomes beyond 1 year in such patients are not known.
Makkar, Raj R   +26 more
core   +1 more source

Transcatheter Aortic Valve Implantation in Dialysis Patients [PDF]

open access: yes, 2012
Background/Aims: Transcatheter aortic valve implantation (TAVI) has emerged as a new therapeutic option for high-risk patients. However, dialysis patients were excluded from all previous studies.
Wessely, Matthias   +6 more
core   +1 more source

Transcatheter versus surgical aortic-valve replacement in high-risk patients. [PDF]

open access: yes, 2011
BACKGROUND: The use of transcatheter aortic-valve replacement has been shown to reduce mortality among high-risk patients with aortic stenosis who are not candidates for surgical replacement.
Makkar, Raj R   +47 more
core   +1 more source

Transcatheter Aortic Valve Replacement Programs: Clinical Outcomes and Developments

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
: Transcatheter aortic valve replacement is a relatively recent revolutionary treatment that has now become a standard procedure for treating severe aortic stenosis.
Vinayak Kumar   +4 more
doaj   +1 more source

Local versus general anesthesia for transcatheter aortic valve implantation (TAVR)- systematic review and meta-analysis [PDF]

open access: yes, 2014
The hypothesis of this study was that local anesthesia with monitored anesthesia care (MAC) is not harmful in comparison to general anesthesia (GA) for patients undergoing Transcatheter Aortic Valve Implantation (TAVR).TAVR is a rapidly spreading ...
Webb, J   +21 more
core   +2 more sources

Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study. [PDF]

open access: yes, 2014
OBJECTIVE: To use patient-level data from the ADVANCE study to evaluate the cost-effectiveness of transcatheter aortic valve implantation (TAVI) compared to medical management (MM) in patients with severe aortic stenosis from the perspective of the UK ...
Busca, R   +32 more
core   +1 more source

Interdisciplinary three-step strategy to treat aortic stenosis and coronary artery disease in a patient with end-stage chronic obstructive pulmonary disease [PDF]

open access: yes, 2012
Background: Valvular aortic stenosis is a common disease in the elderly, often in multimorbid patients. It is often associated with coronary artery disease and peripheral artery disease.
Michel, Sebastian   +6 more
core   +1 more source

Successful Management of Myval Transcatheter Heart Valve Embolization Into Abdominal Aortic Aneurysm During Transcatheter Aortic Valve Replacement [PDF]

open access: yesTexas Heart Institute Journal
Transcatheter heart valve embolization is a serious and rare complication of transcatheter aortic valve replacement. Having a strategy for promptly managing transcatheter heart valve embolization is crucial to avoid emergency conversion from ...
Artemio García-Escobar, MD   +5 more
doaj   +1 more source

Awake Surgical Mitral Valve Repair after Transcatheter Aortic Valve Replacement

open access: yesThe Thoracic & Cardiovascular Surgeon Reports, 2021
Transcatheter aortic valve replacement has become a popular choice for cases with severe aortic stenosis. However, when severe mitral regurgitation is comorbid in high-risk patients with severe aortic stenosis, therapeutic options must be weighed for ...
Aina Hirofuji   +3 more
doaj   +1 more source

Massive TAVR

open access: yesJACC: Case Reports, 2020
A 65-year-old woman with a large adnexal mass was found to have severe bicuspid aortic valve stenosis. Transcatheter aortic valve replacement was chosen rather than surgical aortic valve replacement because of concerns over risks.
Siddharth Chauhan, MD   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy